AI-generated summary
The authors studied whether laser photobiomodulation at 660 nm affects the viability and integration of skin grafts in 20 male Wistar rats split into a treated group and a simulated-treatment control group. They report better graft adhesion, more blood vessels, mast cells and collagen, and higher FGF immunoexpression in the treated animals, and conclude the therapy was effective in promoting graft integration. The study is an animal experiment, so results may not transfer to humans.
- Participants
- 20
- Who or what was studied
- Male Wistar rats (approximately 250 g), 10 per group
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in rats with only 10 animals per group, so findings may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 40 mW
- Total energy
- 2.4 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Photobiomodulation therapy, Control group, Collagen. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.